Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Sell
6,557
-22
-0.3% -$1.03K 0.02% 379
2025
Q4
$319K Buy
6,579
+295
+5% +$14.6K 0.02% 367
2025
Q3
$297K Sell
6,284
-358
-5% -$17.3K 0.02% 378
2025
Q2
$321K Sell
6,642
-783
-11% -$40K 0.02% 336
2025
Q1
$412K Buy
7,425
+716
+11% +$38.8K 0.03% 248
2024
Q4
$324K Buy
6,709
+66
+1% +$3.36K 0.03% 277
2024
Q3
$383K Buy
6,643
+200
+3% +$10.8K 0.03% 241
2024
Q2
$313K Buy
6,443
+234
+4% +$11.3K 0.03% 247
2024
Q1
$302K Buy
6,209
+479
+8% +$23.4K 0.03% 259
2023
Q4
$285K Sell
5,730
-832
-13% -$40.7K 0.03% 244
2023
Q3
$352K Buy
6,562
+364
+6% +$19.4K 0.05% 190
2023
Q2
$334K Buy
6,198
+345
+6% +$18.6K 0.04% 192
2023
Q1
$319K Buy
+5,853
New +$285K 0.04% 185

Other funds holding SNY

PDS Planning's SNY Position: Q1 2026 in Review

PDS Planning reduced its Sanofi (SNY) stake by 0.33% in Q1 2026, selling an estimated $1.03K and leaving 6,557 shares worth $316K. The position accounts for 0.02% of the portfolio, ranked #379.

PDS Planning first reported a position in SNY in Q1 2023 and has held it in 13 quarters since. The position peaked at $412K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • PDS Planning held 6,557 shares of Sanofi worth $316K as of Q1 2026.
  • PDS Planning sold 22 Sanofi shares in Q1 2026, an estimated $1.03K.
  • Sanofi made up 0.02% of PDS Planning's portfolio in Q1 2026, its #379 holding.
  • PDS Planning first reported a position in Sanofi in Q1 2023 and has held it in 13 quarters since.
  • PDS Planning's Sanofi position peaked at $412K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.